Human oligodendroglial cell line, MO3.13, can be protected from apoptosis using the general caspase inhibitor zVAD-FMK

Journal of Neuroscience Research

Volumn 57, Issue 2, 1999, Pages 236-243

  Craighead, Mark W ^a   Tiwari, Priyanka ^a   Keynes, Robert G ^a   Waters, Catherine M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Caspase; Caspase inhibitor; Multiple sclerosis; Oligodendrocyte

Indexed keywords

CASPASE INHIBITOR; UNCLASSIFIED DRUG; Z VAD FMK;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELL LINE; COUMARINS; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENT DYES; HUMANS; IN SITU NICK-END LABELING; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; OLIGOPEPTIDES; STAUROSPORINE; SUBSTRATE SPECIFICITY;

EID: 0033566317     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990715)57:2<236::AID-JNR9>3.0.CO;2-D     Document Type: Article

References (29)

1. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L. 1998. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signalling in the central nervous system of transgenic mice. Am J Pathol 153:801-813.
2. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
3. Barres BA, Raff MC. 1994. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12:935-942.
4. Barres BA, Schmid R, Sendnter M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
5. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y. 1994. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211:314-321.
6. Cohen GM. 1997. Caspases: The executioners of apoptosis. Biochem J 326:1-16.
7. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. 1997. Cell death and birth in multiple sclerosis brain. J Neurol Sci 149:1-11.
8. Dowling P, Shang G, Raval S, Menonna J,Cook S, Husar W. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518
9. Ffrench-Constant C. 1994. Pathogenesis of multiple sclerosis. Lancet 343:271-275.
10. Hennet T, Richter C, Peterhans E. 1993. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J 289:587-592
11. Hisahara S, Shoji S, Okano H, Miura M. 1997. ICE/CED-3 family executes oligodendrocyte apoptosis by tumour necrosis factor. J Neurochem 69:10-20.
12. Hofman F, Hinton D, Johnson K, Merrill J. 1989. Tumour necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
13. Kruman I, Guo Q, Mattson MP. 1998. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 51:293-308.
14. Lucchinetti C, Bruck W, Rodriguez M, Lassmann H. 1996. Distinct patterns of multiple sclerosis pathology indictaes heterogeneity in pathogenesis. Brain Pathol 6:259-274.
15. McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR. 1995. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol 26:283-293.
16. Merrill JE, Benveniste EN. 1996. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci 19:331-338.
17. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63.
18. Navikas V, Link H. 1996. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45:322-333.
19. Nicholson DW, Thornberry NA. 1997. Caspases: Killer proteases. Trends Biochem Sci 22:299-306.
20. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. 1996. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 271: 16443-6.
21. Perron H, Garson JA, Bedin F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, and Mandrand B. 1997. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 94:7583-7588.
22. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual. 2nd edition: Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 18.60-18.85.
23. Sharief M, Hentges R. 1991. Asoociation between tumour necrosis factor -a and disease progression in patients with multiple sclerosis. N Eng J Med 325:467-472
24. Shimizu T, Cao CX, Shao RG, Pommier Y. 1998. Lamin B phosphorylation by protein kinase calpha and proteolysis during apoptosis in human leukemia HL60 cells. J Biol Chem 273:8669-8674.
25. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose): Polymerase. Cell 81:801-809.
26. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, and Nicholson DW. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907-17911.
27. Troy CM, Stefanis L, Greene LA, Shelanski ML. 1997. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurones and PC12 cells. J Neurosci 17:1911-1918
28. Wiesner DA, Dawson G. 1996. Staurosporine induces programmed cell death in embryonic neurones and activation of the ceramide pathway. J Neurochem 66:1418-1425.
29. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.